These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 6722565
21. Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system. Guyenet PG, Javory AF, Beaujouan JC, Rossier BJ, Glowinski J. Brain Res; 1975 Feb 07; 84(2):227-44. PubMed ID: 234276 [Abstract] [Full Text] [Related]
25. Cortical modulation of striatal function. Scatton B, Worms P, Lloyd KG, Bartholini G. Brain Res; 1982 Jan 28; 232(2):331-43. PubMed ID: 6200179 [Abstract] [Full Text] [Related]
26. 6-OHDA-induced lesion of the nigrostriatal dopaminergic neurons potentiates the inhibitory effect of 7-OHDPAT, a selective D3 agonist, on acetylcholine release during striatal microdialysis in conscious rats. Sato K, Ueda H, Okumura F, Misu Y. Brain Res; 1994 Aug 29; 655(1-2):233-6. PubMed ID: 7812777 [Abstract] [Full Text] [Related]
29. Effects of phencyclidine on the release of radioactivity from rat striatal slices labeled with [3H]choline. Leventer SM, Johnson KM. J Pharmacol Exp Ther; 1983 May 29; 225(2):332-6. PubMed ID: 6842397 [Abstract] [Full Text] [Related]
31. Modulation by muscarine and opioid receptors of acetylcholine release in slices from striato-striatal grafts in the rat. Wichmann T, Starke K. Brain Res; 1990 Mar 05; 510(2):296-302. PubMed ID: 2158852 [Abstract] [Full Text] [Related]
33. Dopamine and apomorphine do not modulate the uptake of [3H]D-aspartate in the rat striatum in-vitro. O'Connor I, Cowburn RF, Hardy JA, Fowler CJ. J Pharm Pharmacol; 1988 Apr 05; 40(4):307-8. PubMed ID: 2900322 [Abstract] [Full Text] [Related]
34. Dopamine release is enhanced while acetylcholine release is inhibited by nimodipine (Bay e 9736). Nordström O, Braesch-Andersen S, Bartfai T. Acta Physiol Scand; 1986 Jan 05; 126(1):115-9. PubMed ID: 3953299 [Abstract] [Full Text] [Related]
35. Somatostatin and cholecystokinin octapeptide differentially modulate the release of [3H]acetylcholine from caudate nucleus but not cerebral cortex: role of dopamine receptor activation. Arnerić SP, Reis DJ. Brain Res; 1986 May 21; 374(1):153-61. PubMed ID: 2872939 [Abstract] [Full Text] [Related]
36. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices. Ramírez MJ, Cenarruzabeitia E, Lasheras B, Del Rio J. Brain Res; 1997 May 16; 757(1):17-23. PubMed ID: 9200494 [Abstract] [Full Text] [Related]
38. The effect of apomorphine and bradykinin on uptake and release of dopamine in vitro by striatal synaptosomes of the rat. Borawska M, Wiśniewski K. Pol J Pharmacol Pharm; 1982 May 16; 34(1-3):79-84. PubMed ID: 7167424 [Abstract] [Full Text] [Related]
39. Effects of verapamil on [3H]acetylcholine release in the striatum of spontaneously hypertensive rats. Tsuda K, Tsuda S, Masuyama Y, Goldstein M. Eur J Pharmacol; 1992 Jun 05; 216(2):319-22. PubMed ID: 1397017 [Abstract] [Full Text] [Related]
40. Long-lasting reciprocal changes in striatal dopamine and acetylcholine release upon morphine withdrawal. Tjon Tien Ril HK, De Vries TJ, Wardeh G, Hogenboom F, Mulder AH, Schoffelmeer AN. Eur J Pharmacol; 1993 Apr 28; 235(2-3):321-2. PubMed ID: 8508912 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]